Pedro Cruz researcher (ORCID 0000-0002-3335-9234)
Cruz, Pedro Estilita Pereira Monteiro da
VIAF ID: 100128565 (Personal)
Permalink: http://viaf.org/viaf/100128565
Preferred Forms
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Characterization and downstream processing of HIV-1 core and virus-like-particles produced in serum free medium | |
Downstream processing of lentiviral vectors: releasing bottlenecks. | |
Editorial [Hot topic: GMP Production of Gene and Cell Therapy Therapeutics (Guest Editors: Manuel Carrondo and Pedro Cruz)] | |
Effect of viscosity upon hydrodynamically controlled natural aggregates of animal cells grown in stirred vessels | |
Global optimization of bioprocesses focus on complex bioproducts | |
Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions | |
Hybrid semi-parametric mathematical systems: bridging the gap between systems biology and process engineering. | |
Integrated process optimization: lessons from retrovirus and virus-like particle production. | |
Integrated strategy for the production of therapeutic retroviral vectors | |
Manufacturing of retroviruses | |
Purification of adenoviral vectors using expanded bed chromatography. | |
Purification of recombinant rotavirus VP7 glycoprotein for the study of in vitro rotavirus-like particles assembly | |
Purification of retroviral vectors for clinical application: biological implications and technological challenges | |
Quantitation of MLV-based retroviral vectors using real-time RT-PCR. | |
Regulation of ENaC biogenesis by the stress response protein SERP1. | |
Relevance of an academic GMP Pan-European vector infra-structure (PEVI). | |
Repeated-batch cultures of baby hamster kidney cell aggregates in stirred vessels. | |
Retrovirus producer cell line metabolism: implications on viral productivity. | |
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. | |
Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity. | |
Scaleable purification process for gene therapy retroviral vectors | |
Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors. | |
Screening of novel excipients for improving the stability of retroviral and adenoviral vectors. | |
Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro. | |
Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer | |
Strategies for improved adenovirus and PPR vaccine production in different cell lines from bioprocess development to final formulation | |
Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. | |
Umbilical cord tissue-derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing |